GGrantIndex
← Leaderboards

Jonathan Mark Brown

Wake Forest University Health Sciences

$14,178,789
Attributed
$15,741,650
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.9M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,741,650 · 13

By mechanism

R01$6,772,165 · 5
P01$3,123,400 · 2
P50$2,589,211 · 3
RF1$2,344,291 · 1
R00$732,583 · 1
K99$180,000 · 1

Top collaborators

Most similar at Wake Forest University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsLiverDietMicrobialMolecularIntestinesPathogenesisTrimethylamineLinkTransplantationHepaticCholineMetabolismFmo3LevocarnitineGut MicrobesBile AcidsSignal TransductionReceptorFatty Acid Glycerol EstersGerm-FreeEnzymesAminesFood

Grant awards (39)

Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic Disease$743,302
R01 · FY2025 · HL · contact PI
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury$274,230
P50 · FY2025 · AA · contact PI
Metaorganismal Endocrinology in Cardiometabolic Disease$510,429
R01 · FY2024 · DK · contact PI
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury$274,230
P50 · FY2024 · AA · contact PI
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia$2,344,291
RF1 · FY2023 · NS
Metaorganismal Endocrinology in Cardiometabolic Disease$531,696
R01 · FY2023 · DK · contact PI
Project 2: Gut microbial choline metabolites in cardiometabolic disease$523,250
P01 · FY2023 · HL · contact PI
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury$274,230
P50 · FY2023 · AA · contact PI
Core D: Cardiometabolic Phenotyping Core$257,600
P01 · FY2023 · HL · contact PI
Metaorganismal Endocrinology in Cardiometabolic Disease$531,696
R01 · FY2022 · DK · contact PI
Project 2: Gut microbial choline metabolites in cardiometabolic disease$523,250
P01 · FY2022 · HL · contact PI
The Role of Bacterial Choline Metabolism in Host Stress Responses$391,679
R01 · FY2022 · DK · contact PI
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury$274,230
P50 · FY2022 · AA · contact PI
Core D: Cardiometabolic Phenotyping Core$257,600
P01 · FY2022 · HL · contact PI
Metaorganismal Endocrinology in Cardiometabolic Disease$531,696
R01 · FY2021 · DK · contact PI
Project 2: Gut microbial choline metabolites in cardiometabolic disease$523,250
P01 · FY2021 · HL · contact PI
The Role of Bacterial Choline Metabolism in Host Stress Responses$391,679
R01 · FY2021 · DK · contact PI
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury$274,230
P50 · FY2021 · AA · contact PI
Core D: Cardiometabolic Phenotyping Core$257,600
P01 · FY2021 · HL · contact PI
Project 2: Gut microbial choline metabolites in cardiometabolic disease$523,250
P01 · FY2020 · HL · contact PI
The Role of Bacterial Choline Metabolism in Host Stress Responses$391,073
R01 · FY2020 · DK · contact PI
Core D: Cardiometabolic Phenotyping Core$257,600
P01 · FY2020 · HL · contact PI
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury$249,638
P50 · FY2020 · AA · contact PI
The Role of Bacterial Choline Metabolism in Host Stress Responses$389,246
R01 · FY2019 · DK · contact PI
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury$249,638
P50 · FY2019 · AA · contact PI
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis$396,250
R01 · FY2018 · HL · contact PI
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury$219,510
P50 · FY2018 · AA · contact PI
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis$396,250
R01 · FY2017 · HL · contact PI
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury$249,637
P50 · FY2017 · AA · contact PI
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis$396,250
R01 · FY2016 · HL · contact PI
Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury$249,638
P50 · FY2016 · AA · contact PI
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis$390,306
R01 · FY2015 · HL · contact PI
Functions of intracellular lipid-binding proteins$384,363
R01 · FY2015 · DK · contact PI
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis$396,250
R01 · FY2014 · HL · contact PI
Mechanisms Regulating Non-biliary Fecal Sterol Loss$240,383
R00 · FY2013 · HL · contact PI
Mechanisms Regulating Non-biliary Fecal Sterol Loss$243,200
R00 · FY2012 · HL · contact PI
Mechanisms Regulating Non-biliary Fecal Sterol Loss$249,000
R00 · FY2011 · HL · contact PI
Mechanisms Regulating Non-biliary Fecal Sterol Loss$90,000
K99 · FY2010 · HL · contact PI
Mechanisms Regulating Non-biliary Fecal Sterol Loss$90,000
K99 · FY2009 · HL · contact PI